Well Told Grants

Federal grant programs / Allergy and Infectious Diseases Research

Allergy and Infectious Diseases Research in Kansas

Allergy and Infectious Diseases Research (93.855) awarded $31.3 million to recipients in Kansas in 46 grants from fiscal 2021 to 2025, 0.1% of the program's national total. University of Kansas Medical Center Research Institute, Inc. received the most, $13.2 million.

By year

Grants under this program to recipients in Kansas
Fiscal yearAwardsAmount
FY 202121$8.0 million
FY 202225$8.8 million
FY 202318$6.0 million
FY 202417$3.9 million
FY 202514$4.6 million

Recipients in Kansas

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
University of Kansas Medical Center Research Institute, Inc.Other23$13.2 million
Kansas State UniversityColleges and universities12$10.5 million
University of Kansas Center for Research IncOther9$4.4 million
Acenxion Biosystems IncSmall businesses1$2.9 million
Nectagen IncSmall businesses1$261,060

Counted by the recipient's location. A recipient based in Kansas may carry out the work elsewhere.

Open opportunities under this program

See all 93 on the program page

Questions people ask

How much Allergy and Infectious Diseases Research money goes to Kansas?

$31.3 million from fiscal 2021 to 2025, across 46 awards. Kansas ranks 40th of 52 states and territories for this program.

Who receives Allergy and Infectious Diseases Research money in Kansas?

The largest recipient is University of Kansas Medical Center Research Institute, Inc., with $13.2 million in 23 awards. Next are Kansas State University and University of Kansas Center for Research Inc.

Can organizations in Kansas apply now?

Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Allergy and Infectious Diseases Research in other states

Other large programs in Kansas

All federal grants in Kansas

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.